Ticin for the Treatment of Coronary Lesions With Drug Eluting Ballons

PHASE4RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2030

Conditions
Chronic Coronary Syndrome
Interventions
DEVICE

Magic Touch drug eluting balloon based strategy

Adult patients with chronic coronary syndrome deemed suitable for percutaneous intervention and significant long de-novo coronary lesion randomized in the experimental arm will receive treatment with drug eluting balloon (Magic Touch®) followed by invasive follow up (FFR and IVUS) at 6 ot 12 months in a randomized fashion.

DEVICE

Drug-eluting stent-based strategy

Adult patients with chronic coronary syndrome deemed suitable for percutaneous intervention and significant long de-novo coronary lesion randomized in the control arm will receive treatment with drug-eluting stent followed by invasive follow up (FFR and IVUS) at 6 ot 12 months in a randomized fashion.

Trial Locations (1)

6900

RECRUITING

Marco Valgimigli, Lugano

All Listed Sponsors
collaborator

University of Bern

OTHER

lead

Cardiocentro Ticino

OTHER